Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells

References

• Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol 2016; 13:255-61; PMID:26787282; https://doi.org/10.1038/nrclinonc.2015.224
   PubMed Web of Science ®Google Scholar
• Alipour S, Zoghi S, Khalili N, Hirbod-Mobarakeh A, Emens LA, Rezaei N. Specific immunotherapy in ovarian cancer: a systematic review. Immunotherapy 2016; 8:1193-204; PMID:27605068; https://doi.org/10.2217/imt-2016-0034
   PubMed Web of Science ®Google Scholar
• Ren F, Shen J, Shi H, Hornicek FJ, Kan Q, Duan Z. Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer. Biochim Biophys Acta 2016; 1866:266-75; PMID:27717733
   PubMed Web of Science ®Google Scholar
• Nielsen FC, van Overeem Hansen T, Sorensen CS. Hereditary breast and ovarian cancer: new genes in confined pathways. Nat Rev Cancer 2016; 16:599-612; PMID:27515922; https://doi.org/10.1038/nrc.2016.72
   PubMed Web of Science ®Google Scholar
• Hu J, Zhang WD, Liu RH, Zhang C, Shen YH, Li HL, Liang MJ, Xu XK. Benzophenanthridine alkaloids from Zanthoxylum nitidum (Roxb.) DC, and their analgesic and anti-inflammatory activities. Chem Biodivers 2006; 3:990-5; PMID:17193331; https://doi.org/10.1002/cbdv.200690108
   PubMed Web of Science ®Google Scholar
• Pan X, Han H, Wang L, Yang L, Li R, Li Z, Liu J, Zhao Q, Qian M, Liu M, et al. Nitidine Chloride inhibits breast cancer cells migration and invasion by suppressing c-Src/FAK associated signaling pathway. Cancer Lett 2011; 313:181-91; PMID:21959111; https://doi.org/10.1016/j.canlet.2011.09.001
   PubMed Web of Science ®Google Scholar
• Chen J, Wang J, Lin L, He L, Wu Y, Zhang L, Yi Z, Chen Y, Pang X, Liu M. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Mol Cancer Ther 2012; 11:277-87; PMID:22203730; https://doi.org/10.1158/1535-7163.MCT-11-0648
   PubMed Web of Science ®Google Scholar
• Liao J, Xu T, Zheng JX, Lin JM, Cai QY, Yu DB, Peng J. Nitidine chloride inhibits hepatocellular carcinoma cell growth in vivo through the suppression of the JAK1/STAT3 signaling pathway. Int J Mol Med 2013; 32:79-84; PMID:23613111
   PubMed Web of Science ®Google Scholar
• Sun M, Zhang N, Wang X, Cai C, Cun J, Li Y, Lv S, Yang Q. Nitidine chloride induces apoptosis, cell cycle arrest, and synergistic cytotoxicity with doxorubicin in breast cancer cells. Tumour Biol 2014; 35:10201-12; PMID:25027404; https://doi.org/10.1007/s13277-014-2327-9
   PubMed Web of Science ®Google Scholar
• Kang M, Ou H, Wang R, Liu W, Tang A. The effect of nitidine chloride on the proliferation and apoptosis of nasopharyngeal carcinoma cells. Journal of BUON 2014; 19:130-6; PMID:24659654
   PubMed Web of Science ®Google Scholar
• Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, Xu Z, Liu Z. Nitidine chloride induces apoptosis and inhibits tumor cell proliferation via suppressing ERK signaling pathway in renal cancer. Food and chemical toxicology 2014; 66:210-6; PMID:24508476; https://doi.org/10.1016/j.fct.2014.01.049
   PubMed Web of Science ®Google Scholar
• Zhai H, Hu S, Liu T, Wang F, Wang X, Wu G, Zhang Y, Sui M, Liu H, Jiang L. Nitidine chloride inhibits proliferation and induces apoptosis in colorectal cancer cells by suppressing the ERK signaling pathway. Molecular medicine reports 2016; 13:2536-42; PMID:26847477
   PubMed Web of Science ®Google Scholar
• Chan CH, Morrow JK, Zhang S, Lin HK. Skp2: a dream target in the coming age of cancer therapy. Cell Cycle 2014; 13:679-80; PMID:24526126; https://doi.org/10.4161/cc.27853
   PubMed Web of Science ®Google Scholar
• Fu HC, Yang YC, Chen YJ, Lin H, Ou YC, Chien CC, Huang EY, Huang HY, Lan J, Chi HP, et al. Increased expression of SKP2 is an independent predictor of locoregional recurrence in cervical cancer via promoting DNA-damage response after irradiation. Oncotarget 2016; 7:44047-61; PMID:27317767
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu P, Inuzuka H, Wei W. Roles of F-box proteins in cancer. Nat Rev Cancer 2014; 14:233-47; PMID:24658274; https://doi.org/10.1038/nrc3700
   PubMed Web of Science ®Google Scholar
• Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-9; PMID:10559916; https://doi.org/10.1038/7022110.1038/12013
   PubMed Web of Science ®Google Scholar
• Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol 1999; 9:661-4; PMID:10375532; https://doi.org/10.1016/S0960-9822(99)80290-5
   PubMed Web of Science ®Google Scholar
• Yu ZK, Gervais JL, Zhang H. Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc Natl Acad Sci U S A 1998; 95:11324-9; PMID:9736735; https://doi.org/10.1073/pnas.95.19.11324
   PubMed Web of Science ®Google Scholar
• Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI. Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U S A 2003; 100:10231-6; PMID:12925736; https://doi.org/10.1073/pnas.1831009100
   PubMed Web of Science ®Google Scholar
• Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, Tindall DJ. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci U S A 2005; 102:1649-54; PMID:15668399; https://doi.org/10.1073/pnas.0406789102
   PubMed Web of Science ®Google Scholar
• Wang H, Cui J, Bauzon F, Zhu L. A comparison between Skp2 and FOXO1 for their cytoplasmic localization by Akt1. Cell Cycle 2010; 9:1021-2; PMID:20160512; https://doi.org/10.4161/cc.9.5.10916
   PubMed Web of Science ®Google Scholar
• Shigemasa K, Gu L, O'Brien TJ, Ohama K. Skp2 overexpression is a prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer Res 2003; 9:1756-63; PMID:12738731
   PubMed Web of Science ®Google Scholar
• Sui L, Dong Y, Watanabe Y, Yamaguchi F, Sugimoto K, Tokuda M. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors. Oncol Rep 2006; 15:765-71; PMID:16525656
   PubMed Web of Science ®Google Scholar
• Hafez MM, Alhoshani AR, Al-Hosaini KA, Alsharari SD, Al Rejaie SS, Sayed-Ahmed MM, Al-Shabanah OA. SKP2/P27Kip1 pathway is associated with Advanced Ovarian Cancer in Saudi Patients. Asian Pac J Cancer Prev 2015; 16:5807-15; PMID:26320455; https://doi.org/10.7314/APJCP.2015.16.14.5807
   PubMedGoogle Scholar
• Lu M, Zhao Y, Xu F, Wang Y, Xiang J, Chen D. The expression and prognosis of FOXO3a and Skp2 in human ovarian cancer. Med Oncol 2012; 29:3409-15; PMID:22714061; https://doi.org/10.1007/s12032-011-9919-710.1007/s12032-012-0275-z
   PubMed Web of Science ®Google Scholar
• Lv H, Shi Y, Zhang L, Zhang D, Liu G, Yang Z, Li Y, Fei F, Zhang S. Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor. BMC cancer 2014; 14:576; PMID:25106448; https://doi.org/10.1186/1471-2407-14-576
   PubMed Web of Science ®Google Scholar
• Xu F, Zhu X, Han T, You X, Liu F, Ye L, Zhang X, Wang X, Yao Y. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1. Int J oncology 2014; 45:255-63; PMID:24788380
   PubMed Web of Science ®Google Scholar
• Lin J, Shen A, Chen H, Liao J, Xu T, Liu L, Peng J. Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways. BMC Cancer 2014; 14:729; PMID:25266147; https://doi.org/10.1186/1471-2407-14-729
   PubMed Web of Science ®Google Scholar
• Ou X, Lu Y, Liao L, Li D, Liu L, Liu H, Xu H. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2. Oncol Rep 2015; 33:1264-74; PMID:25530218
   PubMed Web of Science ®Google Scholar
• Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, Shi B, Xu Z, Liu Z. Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway. Food Chem Toxicol 2013; 60:246-51; PMID:23911800; https://doi.org/10.1016/j.fct.2013.07.062
   PubMed Web of Science ®Google Scholar
• Liu M, Wang J, Qi Q, Huang B, Chen A, Li X. Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway. Oncol Rep 2016; 36:2160-8; PMID:27498786
   PubMed Web of Science ®Google Scholar
• Cheng Z, Guo Y, Yang Y, Kan J, Dai S, Helian M, Li B, Xu J, Liu C. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3beta/Snail signaling pathway. Oncol Rep 2016; 36:1023-9; PMID:27279040
   PubMed Web of Science ®Google Scholar
• Sun M, Zhang N, Wang X, Li Y, Qi W, Zhang H, Li Z, Yang Q. Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells. Cell Biosci 2016; 6:44; PMID:27313840; https://doi.org/10.1186/s13578-016-0104-8
   PubMed Web of Science ®Google Scholar
• Sun X, Lin L, Chen Y, Liu T, Liu R, Wang Z, Mou K, Xu J, Li B, Song H. Nitidine chloride inhibits ovarian cancer cell migration and invasion by suppressing MMP-2/9 production via the ERK signaling pathway. Mol Med Rep 2016; 13:3161-8; PMID:26935265
   PubMed Web of Science ®Google Scholar
• Ding F, Liu T, Yu N, Li S, Zhang X, Zheng G, Lv C, Mou K, Xu J, Li B, et al. Nitidine chloride inhibits proliferation, induces apoptosis via the Akt pathway and exhibits a synergistic effect with doxorubicin in ovarian cancer cells. Mol Med Rep 2016; 14:2853-9; PMID:27485415
   PubMed Web of Science ®Google Scholar
• Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A, Stagg LJ, Ladbury JE, Cai Z, Xu D, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013; 154:556-68; PMID:23911321; https://doi.org/10.1016/j.cell.2013.06.048
   PubMed Web of Science ®Google Scholar
• Uddin S, Ahmed M, Hussain AR, Jehan Z, Al-Dayel F, Munkarah A, Bavi P, Al-Kuraya KS. Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer. Lab Invest 2009; 89:1115-27; PMID:19636294; https://doi.org/10.1038/labinvest.2009.75
   PubMed Web of Science ®Google Scholar
• Shi P, Zhang Y, Tong X, Yang Y, Shao Z. Dihydrotestosterone induces p27 degradation via direct binding with SKP2 in ovarian and breast cancer. Int J Mol Med 2011; 28:109-14; PMID:21503567
   PubMed Web of Science ®Google Scholar
• Koo KH, Kim H, Bae YK, Kim K, Park BK, Lee CH, Kim YN. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2. Cell Death Dis 2013; 4:e693; PMID:23807222; https://doi.org/10.1038/cddis.2013.223
   PubMed Web of Science ®Google Scholar
• Su J, Wang L, Yin X, Zhao Z, Hou Y, Ye X, Zhou X, Wang Z. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells. Am J Cancer Res 2016; 6:2178-91; PMID:27822410
   PubMed Web of Science ®Google Scholar
• Yin X, Zhang Y, Su J, Hou Y, Wang L, Ye X, Zhao Z, Zhou X, Li Y, Wang Z. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells. Oncotarget 2016; 7:66512-24; PMID:27582552
   PubMed Web of Science ®Google Scholar
• Wang L, Ye X, Cai X, Su J, Ma R, Yin X, Zhou X, Li H, Wang Z. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells. Oncotarget 2015; 6:18027-37; PMID:26046466; https://doi.org/10.18632/oncotarget.4090
   PubMed Web of Science ®Google Scholar
• Huang HC, Lin CL, Lin JK. 1,2,3,4,6-penta-O-galloyl-beta-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein. J Agric Food Chem 2011; 59:6765-75; PMID:21598989; https://doi.org/10.1021/jf201096v
   PubMed Web of Science ®Google Scholar
• Jia T, Zhang L, Duan Y, Zhang M, Wang G, Zhang J, Zhao Z. The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway. Cancer Cell Int 2014; 14:126; PMID:25530715; https://doi.org/10.1186/s12935-014-0126-4
   PubMed Web of Science ®Google Scholar
• Su J, Zhou X, Wang L, Yin X, Wang Z. Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells. Am J Cancer Res 2016; 6:1949-62; PMID:27725901
   PubMed Web of Science ®Google Scholar
• Lin HP, Lin CY, Huo C, Hsiao PH, Su LC, Jiang SS, Chan TM, Chang CH, Chen LT, Kung HJ, et al. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Oncotarget 2015; 6:6684-707; PMID:25788262; https://doi.org/10.18632/oncotarget.3246
   PubMed Web of Science ®Google Scholar
• Wu L, Wang G, Wei J, Huang N, Zhang S, Yang F, Li M, Zhou G, Wang L. Matrine derivative YF-18 inhibits lung cancer cell proliferation and migration through down-regulating Skp2. Oncotarget 2017; 8:11729-38; PMID:28036296
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhao M, Xu H, Wang K, Fu Z, Jiang Y, Yao Z. RASAL2 down-regulation in ovarian cancer promotes epithelial-mesenchymal transition and metastasis. Oncotarget 2014; 5:6734-45; PMID:25216515; https://doi.org/10.18632/oncotarget.2244
   PubMed Web of Science ®Google Scholar
• Wang L, Hou Y, Yin X, Su J, Zhao Z, Ye X, Zhou X, Zhou L, Wang Z. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells. Oncotarget 2016; 7:69770-82; PMID:27626499
   PubMed Web of Science ®Google Scholar